The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Last updated: June 10, 2024
Sponsor: Wake Forest University Health Sciences
Overall Status: Active - Recruiting

Phase

N/A

Condition

Multiple Myeloma

Leukemia

Hodgkin's Disease

Treatment

N/A

Clinical Study ID

NCT01890486
CCCWFU 95300
  • Ages 18-120
  • All Genders

Study Summary

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion

Exclusion Criteria:

Participation in any other treatment research protocol

Study Design

Total Participants: 2000
Study Start date:
May 21, 2001
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina 27157
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.